Viewing Study NCT02624557


Ignite Creation Date: 2025-12-24 @ 7:00 PM
Ignite Modification Date: 2026-02-20 @ 11:01 AM
Study NCT ID: NCT02624557
Status: COMPLETED
Last Update Posted: 2020-12-09
First Post: 2015-12-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetic Study of Alpelisib in Subjects With Hepatic Impairment.
Sponsor: Novartis Pharmaceuticals
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CBYL719A2105
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators